|
|
||||||||
|
FIGURE 4. Mass with intense 18F-FDG uptake as seen in Figures 2 and 3 shows a positive reaction for both Glut 1 and HK II and, additionally, the biliary marker CK-19 (patient 7) (x400). Morphologically, lesion is classified as an HCC; however, biologically, it has both HCC and cholangiocarcinoma phenotypes.
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |